Its being studied for more (addiction, mental health, Alzheimers) Prices are coming down (Zepbound is 20% less expensive than Wegovy) But, on the other hand: Medicare is legally prevented from covering GLP1s for obesity Only 16 states cover anti-obesity medications under Medicaid 50% or less commercial plans cover GLP1s for obesity, and those that do often have unreasonable hurdles Covered can still mean $500-1000 out of pocket every month
Some additional off label uses include treatment of aggression, impulsivity, agitation, schizophrenia, and alcohol abuse
This isnt just a product its a movement
Almost too well
Given the many factors that come into play when deciding on the most appropriate choice of treatment for T2DM in an individual patient, in the context of GLP-1RAs, a clinical decision algorithm that incorporates author opinion is proposed
Ensure you use the fat before you lose it to gain volume where you want it: In the face, buttocks, and breasts